Form 4 for PLAB PHOTRONICS INC
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0001567619-22-000387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-04 | 2022-01-03 | PLAB | Progler Christopher J | EVP, CTO | F - Tax | $18.99 | -10.2K | 126.7K | -7% | -$194.2K |
| D | 2022-01-04 | 2021-12-31 | PLAB | Progler Christopher J | EVP, CTO | S - Sale+OE | $19.00 | -9,000 | 129.8K | -6% | -$171.0K |
| D | 2022-01-04 | 2021-12-31 | PLAB | Progler Christopher J | EVP, CTO | M - OptEx | $8.86 | +9,000 | 138.8K | +7% | +$79.7K |
| D | 2022-01-04 | 2022-01-03 | PLAB | Progler Christopher J | EVP, CTO | A - Grant | $0.00 | +40.0K | 159.6K | +33% | $0 |
| D | 2022-01-04 | 2021-12-31 | PLAB | Progler Christopher J | EVP, CTO | M - OptEx | $0.00 | -9,000 | 9,688 | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | F | D | 3,633 | $18.85 | 119,593 | D | — | — | (F5) Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 2, 2021. |
| 2 | Common | Common Stock | 2022-01-03 | F | D | 3,444 | $19.28 | 123,226 | D | — | — | (F4) Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 3, 2020. |
| 3 | Common | Common Stock | 2022-01-03 | F | D | 3,148 | $18.85 | 126,670 | D | — | — | (F3) Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 2, 2019. |
| 4 | Common | Common Stock | 2021-12-31 | S | D | 9,000 | $19.00 | 129,818 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Progler. (F2) Net proceeds of sale to fund children's education and offset a tax liability from Restricted Stock Vesting. |
| 5 | Common | Common Stock | 2021-12-31 | M | A | 9,000 | $8.86 | 138,818 | D | — | — | |
| 6 | Common | Common Stock | 2022-01-03 | A | A | 40,000 | $0.00 | 159,593 | D | — | — | (F6) 25% of the Restricted Stock Awards granted will vest on each anniversary date of the grant over 4 years. |
| 7 | Derivative | Stock Options (Right to Buy) | 2021-12-31 | M | D | 9,000 | $0.00 | 9,688 | D | $8.86 · 2017-12-13 to 2023-12-13 | 9,000 Common Stock |